BrickBio Spins Out EnCapsid: A Novel Gene Therapy Company that Creates Novel AAVs and Enables More Efficient, CRISPR Cas-9 Delivery
BOSTON, Jan. 7, 2021 /PRNewswire/ — BrickBio, backed by Tiger Gene, L.L.C., has spun out EnCapsid, a first-in-class gene therapy company focused on developing enhanced adeno-associated virus (AAV) delivery vectors using a technology that enables precise modification of all natural and…
Comments Off on BrickBio Spins Out EnCapsid: A Novel Gene Therapy Company that Creates Novel AAVs and Enables More Efficient, CRISPR Cas-9 Delivery